Contrast-enhanced magnetic resonance imaging of the breast: Interpretation guidelines

Topics in Magnetic Resonance Imaging

Volumn 9, Issue 1, 1998, Pages 17-43

  Viehweg, Petra ^a   Paprosch, Iris ^a   Strassinopoulou, Myrsini ^a   Heywang Köbrunner, Sylvia H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Breast; Contrast enhancement; Magnetic resonance imaging; Tissue characterization

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST ENDOPROSTHESIS; CANCER ADJUVANT THERAPY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; HORMONE SUBSTITUTION; HUMAN; MENSTRUAL CYCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCIBILITY;

ADULT; ARTIFACTS; BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PRACTICE GUIDELINES; SENSITIVITY AND SPECIFICITY;

EID: 0031862547     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Heywang S H, Hilbertz T, Beck R, Bauer WM, Eiermann W, Permanetter W. Gd-DTPA enhanced MR imaging of the breast in patients with postoperative scarring and silicon implants. J Comput Assist Tomogr 1990;14:348-56.
2. Heywang-Köbrunner SH, Schlegel A, Beck R, et al. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy. J Comput Assist Tomogr 1993;17:891-900.
3. Boné B, Aspelin P, Isberg B, Perbeck L, Veress B. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery. Acta Radiol 1995;36:111-6.
4. Sickles EA, Filly RA, Callen PW. Breast cancer detection with sonography and mammography: Comparison using state-of-the-art equipment. AJR 1983;140:843-5.
5. Kopans DB, Meyer JE, Linfors KK. Whole-breast US imaging: Four year follow-up. Radiology 1985;157:505-7.
6. Bassett LW, Kimme-Smith C. Breast sonography. AJR 1991;156: 449-55.
7. Liberman L, Dershaw DD, Rosen PP, et al. Stereotaxic 14-gauge breast biopsy: How many specimens are needed? Radiology 1994;192:793-5.
8. Parker SH, Burbank F, Jackmann RJ, et al. Percutaneous breast biopsy: A multiinstitutional study. Radiology 1994;193:359-64.
9. Heywang SH, Hahn D, Schmid H, et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 1986;10:199-204.
10. Ottinetti A, Sapino A. Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res Treat 1988;11:241-8.
11. Dresel V, Buhner M, Schulz-Wendtland R, Bauer M. Intraduktale Karzinome der Mamma: ist eine Diagnose in der Kernspintomographie möglich? Radiologe 1995;35:87.
12. Heywang-Köbrunner SH, Wolf HD, Deimling M, Kösling S, Höfer H, Spielmann RP. Misleading changes of signal intensity on opposed-phase MRI after injection of contrast medium. J Comput Assist Tomogr 1996;20:173-8.
13. Heywang-Köbrunner SH, Haustein J, Pohl C, et al. Contrast-enhanced MR imaging of the breast: Comparison of two different doses of gadopentetate dimeglumine. Radiology 1994;191:639-46.
14. Beck R, Heywang-Köbrunner SH, Untch M. Contrast-enhancement of proliferative dysplasia in MRI of the breast due to the menstrual cycle. In: Peters PE, ed. European Congress of Radiology 93. Berlin/Heidelberg/New York: Springer, 1993:151.
15. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: Normal contrast medium enhancement and cyclical-phase dependency. Radiology 1997;203:137-44.
16. Müller-Schimpfle M, Ohmenhäuser K, Stell P, Dietz K, Claussen CD. Menstrual cycle and age: Influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 1997;203:145-9.
17. Oellinger H, Heins S, Sander B, et al. Gd-DTPA enhanced MR of breast: The most sensitive method for detecting multicentric carcinomas in female breast? Eur Radiol 1993;3:223-6.
18. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation. Radiology 1993;187:493-501.
19. Fischer U, Vossenhenrich R, Probst A, Burchhardt H, Grabbe E. Preoperative MR mammography in patients with breast cancer: Useful information or useless extravagance? Fortschr Röntgenstr 1994;161:300-6.
20. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: Effect of MR imaging and MR-guided biopsy. Radiology 1995;156:115-22.
21. Heywang-Köbrunner SH. Contrast-enhanced magnetic resonance of the breast. Invest Radiol 1994;96:94-104.
22. Orel SG, Mendonca MH, Reynolds C, Schnall MD, Solin LJ, Sullivan DC. MR imaging of ductal carcinoma in situ. Radiology 1997;202: 413-20.
23. Boetes C, Mus RD, Holland R, et al. Breast tumors: Comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995;197:743-7.
24. Krämer S, Döinghaus K, Schulz-Wendtland R, Lang N, Bautz W. Magnetic imaging and its role for the diagnosis of multicentric breast cancer. Eur Radiol 1997;7(suppl):184.
25. Cooney BS, Orel SG, Schnall MD, Troupin RH. Invasive lobular carcinoma in a patient with synchronous ductal carcinoma in situ: Detection with MR imaging. AJR 1994;162:1318-20.
26. Dilcher-Spies S, Venator M. Diagnostische Wertigkeit der MR-Mammographie bei lobulärem Mamma-Carcinom. Retrospektive Analyse von 17 Patienten. Radiologe 1995;35/4:81.
27. Wilhelm K, Grebe P, Teifke A, Halbsguth A, Mitze M, Thelen M. MR-tomographic appearance of invasive lobular carcinoma of the breast. Akt Radiol 1992;2:373-5.
28. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 1994;193:777-81.
29. Heywang-Köbrunner SH, Requardt H, Huynh A, et al. MRI of the breast: First experiences with a new localisation device. Eur Congr Radiol 1993;93:204.
30. Heywang-Köbrunner SH, Huynh A, Viehweg P, Hanke W, Requardt H, Paprosch I. Prototype breast coil for MR-guided needle localization. J Comput Assist Tomogr 1994;18:867-81.
31. Fischer U, Vossenhenrich R, Keating D, et al. MR-guided biopsy of suspect breast lesions with a simple sterotaxic add-on device for surface coils. Radiology 1994;192:272-3.
32. Orel SG, Schnall MD, Newman RW, Powell CM, Torosian MH, Rosato EF. MR imaging-guided localization and biopsy of breast lesions: Initial experience. Radiology 1994;193:97-102.
33. Homer MI. Mammographic interpretation: A practical approach. New York:McGraw-Hill, 1991:4-5.
34. Solin LI. Special considerations. In: Fowble B, Goodmann RL, Glick IH, Rosato EF, eds. Breast cancer treatment: A comprehensive guide to management. St. Louis: Mosby, 1991:523-8.
35. Heywang-Köbrunner SH, Beck R. Contrast-enhanced MRI of the breast. Berlin/Heidelberg/New York: Springer-Verlag, 1995.
36. Porter BA, Smith JP, Borrow IW. MR depiction of occult breast cancer in patients with malignant axillary adenopathy. Radiology 1995;197(suppl):130.
37. Beatty SM, Orel SG, Schall MD, Weinreb JC, Harms SE, Stomper PC. MR imaging detection of occult breast carcinoma manifesting as axillary metastases. Radiology 1996; 201(suppl):129.
38. van Die LE, Boetes C, Barentsz MD, Ruys MD. Additional value of MR imaging of the breast in women with pathologic axillary lymph nodes and normal mammogramms. Radiology 1996;201(suppl): 241.
39. Morris EA, Schwartz LH, Dershaw DD, Liberman L, Abramson AF. Breast MR in patients with occult primary cancer. Radiology 1996;201(suppl 10):129.
40. Heinig A, Heywang-Köbrunner SH, Viehweg P, Lampe D, Buchmann J, Spielmann RP. Value of contrast-enhanced MRI of the breast after reconstruction with silicon implant. Der Radiologe, in press.
41. Heywang-Köbrunner SH, Schreer I. Bildgebende mammadiagnostik. New York/Stuttgart: Georg Thieme Verlag, 1996.
42. Fischer U, Vossenhenrich R, Kopka L, Kahlen O, Grabbe E. Kontrast-mittelgestützte dynamische MR-Mammographie nach diagnostischen und therapeutischen Eingriffen an der Mamma. Bildgebung 1996;63:1-7.
43. Lewis-Jones HG, Whitehouse GH, Leinster SJ. The role of magnetic resonance imaging in the assessment of local recurrent breast carcinoma. Clin Radiology 1991;43:197-204.
44. Dao TH, Rahmouni A, Campana F, Laurent M, Asselain B, Fourquet A. Tumor recurrence versus fibrosis in the irradiated breast: Differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993;187:751-5.
45. Gilles R, Guinebretiere JM, Shapeero LG, et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: Preliminary results in 26 patients. Radiology 1993;188:473-8.
46. Schulz-Wendtland R, Krämer S, Döinghaus K, Lang N, Bautz W. MR mammography in the diagnosis of local recurrences in breast cancer. Eur Radiol 1997;7(suppl):242.
47. Gilles R, Guinebretiere JM, Toussaint C. et al. Locally advanced breast cancer: Contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994;191:633-8.
48. Knopp MV, Brix G, Junkermann HJ, Sinn HP. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. In: Davis, P. L., ed. Magnetic resonance imaging: Clin North Am Breast Imaging 1994;2-4:633-8.
49. Wurdinger S, Straube K, Michaelsen S, et al. Evaluation of neoadjuvant chemotherapy of breast cancer by MR mammography: Preliminary results. Eur Radiol: 1997;7:624.
50. Heywang-Köbrunner SH, Viehweg P, Heinig A, Küchler, C. Contrast-enhanced MRI of the breast: Accuracy, value, controversies, solutions. Eur J Radiol 1997;24:94-108.